Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs Lockheed Martin Corporation (LMT) Price & Performance

Axogen IncTrade
Lockheed Martin CorporationTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Lockheed Martin Corporation — how do they compare? Axogen Inc trades at $48.35 (market cap $2.59B), while Lockheed Martin Corporation trades at $597 (market cap $139.20B). The key difference: Lockheed Martin Corporation is far larger — about 53.7× Axogen Inc's market cap, and Lockheed Martin Corporation pays a 2.29% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

AXGNLMT
Market Cap
$2.59B$139.20B
Sector
TechnologyIndustrials
52-Week High
$48.48$676.70
52-Week Low
$14.16$431.56
Enterprise Value
$2.50B$155.95B
Dividend Yield
2.29%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN is trading at $46.43, up 4.69% today, with strong technical momentum and bullish moving average signals. The company reported Q2 2026 revenue growth of 23.1% to $69.7 million and raised full-year guidance to at least $279 million. Despite recent earnings misses, analyst sentiment remains overwhelmingly positive with 84% buy ratings and a $54.33 price target.

The stock presents growth potential driven by expanding nerve care platform adoption and reimbursement improvements, but faces risks from persistent net losses (-$15.7M in 2025) and high valuation multiples (P/S 9.5). Near-term performance hinges on Q3 earnings delivery and continued commercial execution amid competitive pressures.

Lockheed Martin Corporation

Lockheed Martin (LMT) trades at $587.95, up 0.9% with bullish technical signals and strong institutional support. The company reported mixed Q2 2026 earnings with a beat on EPS ($7.94 vs. $7.22 expected) but maintains a record $230B backlog. Valuation metrics show a P/E of 21.68 and ROE of 89.16%, though recent quarters saw earnings misses. Technical indicators suggest bullish momentum with key resistance at $592.

Outlook remains positive driven by defense contract wins and production expansion, but risks include execution on massive backlog and debt levels. Analyst consensus is bullish with $608 price target representing 3.4% upside. The stock offers stability through dividends ($3.45 quarterly) amid geopolitical demand for defense systems.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About Lockheed Martin Corporation

Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.

Read more on LMT